Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 12, 2011, Pages 1773-1783

  Gast, Marie Christine W ^a   Zapatka, Marc ^b   Van Tinteren, Harm ^c   Bontenbal, Marijke ^d   Span, Paul N ^e   Tjan Heijnen, Vivianne C G ^f   Knol, Jaco C ^g   Jimenez, Connie R ^g   Schellens, Jan H M ^c,h   Beijnen, Jos H ^a,h  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Anion exchange fractionation; Breast cancer; Prognostic markers; Recurrence free survival; SELDI TOF MS; Serum

Indexed keywords

INTER ALPHA TRYPSIN INHIBITOR; PEPTIDE;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL PROTEOMICS; HEAVY CHAIN; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LONGITUDINAL STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 82955211266     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1055-4     Document Type: Article

References (29)

1. J Albrethsen 2007 Reproducibility in protein profiling by MALDI-TOF mass spectrometry Clin Chem 53 5 852 858 17395711 10.1373/clinchem.2006.082644 1:CAS:528:DC%2BD2sXltFyqtro%3D (Pubitemid 46744240)
2. NL Anderson NG Anderson 2002 The human plasma proteome: history, character, and diagnostic prospects Mol Cell Proteomics 1 11 845 867 12488461 10.1074/mcp.R200007-MCP200 1:CAS:528:DC%2BD3sXht1Ciug%3D%3D
3. RE Banks MJ Dunn DF Hochstrasser JC Sanchez W Blackstock DJ Pappin, et al. 2000 Proteomics: new perspectives, new biomedical opportunities Lancet 356 9243 1749 1756 11095271 10.1016/S0140-6736(00)03214-1 1:CAS:528: DC%2BD3cXosFeks7w%3D
4. R Demicheli MW Retsky DE Swartzendruber G Bonadonna 1997 Proposal for a new model of breast cancer metastatic development Ann Oncol 8 11 1075 1080 9426326 10.1023/A:1008263116022 1:STN:280:DyaK1c%2FoslOjtA%3D%3D (Pubitemid 27521214)
5. R Demicheli MW Retsky WJ Hrushesky M Baum ID Gukas 2008 The effects of surgery on tumor growth: a century of investigations Ann Oncol 19 11 1821 1828 18550576 10.1093/annonc/mdn386 1:STN:280:DC%2BD1cnosVClug%3D%3D
6. Early Breast Cancer Trialists' Collaborative Group 1998 Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 352 9132 930 942 10.1016/S0140-6736(98)03301-7 (Pubitemid 28427277)
7. B Fisher N Gunduz J Coyle C Rudock E Saffer 1989 Presence of a growth-stimulating factor in serum following primary tumor removal in mice Cancer Res 49 8 1996 2001 2702641 1:CAS:528:DyaL1MXitFSisbY%3D (Pubitemid 19106503)
8. JA Foekens D Atkins Y Zhang FC Sweep N Harbeck A Paradiso, et al. 2006 Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 24 11 1665 1671 16505412 10.1200/JCO.2005.03.9115 1:CAS:528:DC%2BD28XksVKgtLo%3D (Pubitemid 46622137)
9. ET Fung TT Yip L Lomas Z Wang C Yip XY Meng, et al. 2005 Classification of cancer types by measuring variants of host response proteins using SELDI serum assays Int J Cancer 115 5 783 789 15704152 10.1002/ijc.20928 1:CAS:528:DC%2BD2MXkvF2ksLw%3D (Pubitemid 40776702)
10. MC Gast H van Tinteren M Bontenbal QC van Hoesel MA Nooij S Rodenhuis, et al. 2009 Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients BMC Cancer 8 389 10.1186/1471-2407-8-389
11. A Goldhirsch WC Wood RD Gelber AS Coates B Thurlimann HJ Senn 2003 Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer J Clin Oncol 21 17 3357 3365 12847142 10.1200/JCO.2003.04.576 (Pubitemid 46606270)
12. A Goncalves B Esterni F Bertucci R Sauvan C Chabannon M Cubizolles, et al. 2006 Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy Oncogene 25 7 981 989 16186794 10.1038/sj.onc.1209131 1:CAS:528: DC%2BD28XhsVeiurw%3D (Pubitemid 43277006)
13. R Heimann S Hellman 2000 Individual characterisation of the metastatic capacity of human breast carcinoma Eur J Cancer 36 13 Spec No 1631 1639 10959049 10.1016/S0959-8049(00)00151-9 1:CAS:528:DC%2BD3cXlvFSrs7c%3D (Pubitemid 30616367)
14. SA Hoffman WA Joo LA Echan DW Speicher 2007 Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma J Chromatogr B Analyt Technol Biomed Life Sci 849 1-2 43 52 17140865 1:CAS:528:DC%2BD2sXjvFeit7o%3D (Pubitemid 46529317)
15. TW Hutchens TT Yip 1993 New desorption strategies for the mass spectrometric analysis of macromolecules Rapid Commun Mass Spectrom 7 576 580 10.1002/rcm.1290070703 1:CAS:528:DyaK3sXlslKqtrg%3D
16. A Jemal R Siegel E Ward Y Hao J Xu T Murray, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 2 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
17. CR Jimenez Z El Filali JC Knol K Hoekman FAE Kruyt G Giaccone, et al. 2007 Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS Proteomics Clin Appl 1 6 598 604 21136711 10.1002/prca.200600483 1:CAS:528:DC%2BD2sXntlCqs7w%3D
18. SM Pupa S Menard S Forti E Tagliabue 2002 New insights into the role of extracellular matrix during tumor onset and progression J Cell Physiol 192 3 259 267 12124771 10.1002/jcp.10142 1:CAS:528:DC%2BD38XlvFertb8%3D (Pubitemid 34827603)
19. G Ricolleau C Charbonnel L Lode D Loussouarn MP Joalland R Bogumil, et al. 2006 Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors Proteomics 6 6 1963 1975 16470659 10.1002/pmic.200500283 1:CAS:528:DC%2BD28XjtlKmt7k%3D
20. S Rodenhuis M Bontenbal LV Beex J Wagstaff DJ Richel MA Nooij, et al. 2003 High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer N Engl J Med 349 1 7 16 12840087 10.1056/NEJMoa022794 1:CAS:528:DC%2BD3sXltFGkurs%3D (Pubitemid 36765098)
21. J Song M Patel CN Rosenzweig Y Chan-Li LJ Sokoll ET Fung, et al. 2006 Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay Clin Chem 52 6 1045 1053 16574760 10.1373/clinchem.2005.065722 1:CAS:528: DC%2BD28XltlSrtb4%3D (Pubitemid 43794416)
22. LJ 't Veer H Dai MJ van de Vijver YD He AA Hart M Mao, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536 11823860 10.1038/415530a (Pubitemid 34130608)
23. E Tagliabue R Agresti ML Carcangiu C Ghirelli D Morelli M Campiglio, et al. 2003 Role of HER2 in wound-induced breast carcinoma proliferation Lancet 362 9383 527 533 12932384 10.1016/S0140-6736(03)14112-8 1:CAS:528: DC%2BD3sXmsVartbc%3D (Pubitemid 36980657)
24. JF Timms E Arslan-Low A Gentry-Maharaj Z Luo D T'Jampens VN Podust, et al. 2007 Preanalytic influence of sample handling on SELDI-TOF serum protein profiles Clin Chem 53 4 645 656 17303688 10.1373/clinchem.2006.080101 1:CAS:528:DC%2BD2sXksFWhtb4%3D (Pubitemid 46580234)
25. MJ van de Vijver YD He LJ van't Veer H Dai AA Hart DW Voskuil, et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 25 1999 2009 12490681 10.1056/NEJMoa021967 (Pubitemid 35461656)
26. I van den Broek RW Sparidans JH Schellens JH Beijnen 2008 Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum Rapid Commun Mass Spectrom 22 18 2915 2928 18752334 10.1002/rcm.3695
27. J Villanueva J Philip CA Chaparro Y Li R Toledo-Crow L DeNoyer, et al. 2005 Correcting common errors in identifying cancer-specific serum peptide signatures J Proteome Res 4 4 1060 1072 16083255 10.1021/pr050034b 1:CAS:528:DC%2BD2MXjtFehsLY%3D (Pubitemid 41208664)
28. J Villanueva DR Shaffer J Philip CA Chaparro H Erdjument-Bromage AB Olshen, et al. 2006 Differential exoprotease activities confer tumor-specific serum peptidome patterns J Clin Invest 116 1 271 284 16395409 10.1172/JCI26022 1:CAS:528:DC%2BD28XjslOgtQ%3D%3D (Pubitemid 43121812)
29. Y Wang JG Klijn Y Zhang AM Sieuwerts MP Look F Yang, et al. 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 9460 671 679 15721472 1:CAS:528: DC%2BD2MXhsVOitLk%3D (Pubitemid 40260888)